NCCN Works to Improve Global Cancer Care for Children with Newly Translated Recommendations
PR84378
PLYMOUTH MEETING, Pennsylvania, June 17, 2020 /PRNewswire=KYODO JBN/ --
- NCCN Guidelines for Pediatric Acute Lymphoblastic Leukemia in Chinese,
Japanese, French, Spanish, and Portuguese are now available for free at NCCN.org
The National Comprehensive Cancer Network(R) (NCCN(R)) (
https://c212.net/c/link/?t=0&l=en&o=2829309-1&h=2918581852&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN
) —an alliance of leading cancer centers (
) in the United States—is announcing the publication of translated versions of
the NCCN Guidelines(R) (
) for Pediatric Acute Lymphoblastic Leukemia (ALL) (
) into Chinese, French, Japanese, Portuguese, and Spanish. Pediatric ALL is the
most common type of cancer in children, but is highly curable when treated with
contemporary and evidence-based approaches.[1] NCCN Guidelines are written and
updated by leading authorities across various health disciplines. They include
the most comprehensive and up-to-date recommendations for treating patients,
including children, with cancer outside of a clinical trial setting.
Photo -
Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg
"More young lives could be saved through the application of widely-available,
evidence-based treatments," said Robert W. Carlson, MD, Chief Executive
Officer, NCCN. "Advances in the fight against pediatric ALL have been
remarkable in recent years. We can improve the cure rate even further by making
sure best practices are reaching every corner of the earth. We get closer to
achieving this goal by making evidence-based, expert consensus-driven NCCN
Guidelines more accessible to non-English speakers."
The English-language version of NCCN Guidelines for Pediatric ALL was first
published (
) in May of 2019. The recommendations cover typical treatment algorithms, such
as multi-agent chemotherapy regimens, as well as emerging innovations in
targeted therapy and chimeric antigen receptor (CAR) T-cell therapy, a type of
immunotherapy. The guidelines are intended for the management of patients from
birth through adolescence and into young adulthood.
"These NCCN Guidelines include a strong focus on supportive care in order to
reduce potentially dangerous side-effects for children undergoing treatment,"
explained Dr. Carlson. "They also help identify vulnerable populations, such as
infants or patients with Down syndrome, and provide specific recommendations
for keeping them as safe as possible, both short- and long-term."
The translated guidelines are available free-of-charge for non-commercial use
at NCCN.org/global (
) or via the Virtual Library of NCCN Guidelines(R) App (
).
The NCCN Global Department constantly updates and expands adaptations and
translations of NCCN Guidelines for all major cancer types plus supportive care
and prevention. More than 40 new translations have published this year alone,
including clinical guidelines and patient-friendly versions (
). NCCN also provides NCCN Framework for Resource Stratification of NCCN
Guidelines (NCCN Framework(TM) -
) and NCCN Harmonized Guidelines(TM) (
) with optimal recommendations alongside pragmatic approaches for adapting
treatment in resource-constrained settings, such as low- and middle-income
countries. Visit AlliedAgainstCancer.org (
) to learn about NCCN's ongoing work in Sub-Saharan Africa with the African
Cancer Coalition, American Cancer Society (
), Clinton Health Access Initiative (
), and IBM (
https://c212.net/c/link/?t=0&l=en&o=2829309-1&h=502629562&u=https%3A%2F%2Fwww.ibm.org%2F&a=IBM
).
Free recommendations for self-care and stress management for cancer patients,
caregivers, and providers during the COVID-19 pandemic are now available in
English, Chinese, and Spanish at NCCN.org/covid-19 (
).
Visit NCCN.org/global (
) for more on everything the organization is doing to improve cancer care
worldwide, and join the conversation online with the hashtag #NCCNGlobal (
).
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network(R) (NCCN(R)) (
https://c212.net/c/link/?t=0&l=en&o=2829309-1&h=2918581852&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN
) is a not-for-profit alliance of leading cancer centers (
) devoted to patient care, research, and education. NCCN is dedicated to
improving and facilitating quality, effective, efficient, and accessible cancer
care so patients can live better lives. The NCCN Clinical Practice Guidelines
in Oncology (NCCN Guidelines(R)) (
) provide transparent, evidence-based, expert consensus recommendations for
cancer treatment, prevention, and supportive services; they are the recognized
standard for clinical direction and policy in cancer management and the most
thorough and frequently-updated clinical practice guidelines available in any
area of medicine. The NCCN Guidelines for Patients(R) (
) provide expert cancer treatment information to inform and empower patients
and caregivers, through support from the NCCN Foundation(R) (
). NCCN also advances continuing education (
), global initiatives (
), policy (
), and research collaboration (
) and publication (
) in oncology. Visit NCCN.org (
https://c212.net/c/link/?t=0&l=en&o=2829309-1&h=1174645075&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN.org
) for more information and follow NCCN on Facebook @NCCNorg (
), Instagram @NCCNorg (
), and Twitter @NCCN (
).
[1] Esparza SD, Sakamoto KM, Topics in pediatric leukemia-acute lymphoblastic
leukemia. MedGenMed 2005;7:23. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/16369328. Ma H, Sun H Sun X. Survival
improvement by decade of patients aged 0-14 years with acute lymphoblastic
leukemia: a SEER analysis. Sci Rep 2014;4:4227. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/24572378.
Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org
SOURCE National Comprehensive Cancer Network
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
